trihexyphenidyl has been researched along with dihydroxyphenylalanine in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 36 (97.30) | 18.7374 |
1990's | 1 (2.70) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fahn, S; Marsden, CD; Nygaard, TG | 1 |
Accornero, N; Agnoli, A; Casacchia, M; Ruggieri, S; Volante, F | 1 |
Bianchi, C; Tomasi, L | 1 |
Consolo, S; Garattini, S; Ladinsky, H | 1 |
Gressier, H; Malecot, E; Poignant, JC | 1 |
Jurna, I; Lanzer, G | 1 |
Bachmann, T; Jurna, I; Theres, C | 1 |
Chase, TN | 1 |
Klawans, HL | 1 |
Abramsky, O; Lavy, S; Marks, ES | 1 |
RodrĂguez, R | 1 |
Dinapoli, RP; Muenter, MD; Sharpless, NS; Tyce, GM | 1 |
Benesová, O | 1 |
Presthus, J | 1 |
Bulandra, R; Ciuca, I; Ninosu, N; Serbanesco, A | 1 |
Davis, RL; Wolf, SM | 1 |
Martinez, AJ; Utterback, RA | 1 |
Cotzias, GC; Lawrence, WH; Papavasiliou, PS | 1 |
Brait, K; Fahn, S; Schwarz, GA | 1 |
Siegfried, J | 1 |
Horrocks, PM; Marsden, CD; Parkes, JD; Rees, JE; Vicary, DJ | 1 |
Lampert, PW; London, GW; Powell, HC | 1 |
Chase, TN; Glaubiger, GA; Woods, AC | 1 |
Kastin, AJ; Plotnikoff, NP | 1 |
Baxter, RC; Marsden, CD; Parkes, JD; Rees, JE | 1 |
Knopp, W | 1 |
Hirayama, K; Kato, N; Nagao, Y; Nakanishi, T; Uono, M | 1 |
Lackowska, H; Maksymowicz, B; Stelmasiak, Z | 1 |
Florio, V; Longo, VG | 1 |
De Carolis, AS; Loizzo, A; Longo, VG | 1 |
Butz, P; Kaufmann, W; Wiesendanger, M | 1 |
Dana, L; Merlis, S; Wolpert, A; Yaryura-Tobias, JA | 1 |
Dodge, PR; Guggenheim, MA | 1 |
Van Woert, MH; Weintraub, MI | 1 |
Gjerris, F | 1 |
Hughes, RC; Polgar, JG; Walton, JN; Weightman, D | 1 |
4 review(s) available for trihexyphenidyl and dihydroxyphenylalanine
Article | Year |
---|---|
Drug-induced extrapyramidal disorders.
Topics: Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Benztropine; Dihydroxyphenylalanine; Dopamine; Drug-Related Side Effects and Adverse Reactions; Extrapyramidal Tracts; Haloperidol; Humans; Methyltyrosines; Movement Disorders; Phenothiazines; Phenylacetates; Probenecid; Reserpine; Synaptic Transmission; Tetrabenazine; Tranquilizing Agents; Trihexyphenidyl | 1972 |
The pharmacology of parkinsonism (a review).
Topics: Acetylcholine; Animals; Atropa belladonna; Atropine; Central Nervous System; Chlorpromazine; Dextroamphetamine; Dihydroxyphenylalanine; Diphenhydramine; Dopa Decarboxylase; Dopamine; Drug Synergism; Epinephrine; Haloperidol; Histamine H1 Antagonists; Humans; Mice; Monoamine Oxidase; Norepinephrine; Parkinson Disease; Parkinson Disease, Secondary; Peripheral Nerves; Phytotherapy; Plants, Medicinal; Plants, Toxic; Reserpine; Trihexyphenidyl | 1968 |
[Review of current pharmacotherapy of Parkinsonism. Comprehensive review].
Topics: 5-Hydroxytryptophan; Amantadine; Anticonvulsants; Apomorphine; Benztropine; Carboxy-Lyases; Chemical Phenomena; Chemistry; Dihydroxyphenylalanine; Humans; Parasympatholytics; Parkinson Disease; Procyclidine; Trihexyphenidyl | 1973 |
[Factors which influence infavourably l-dopa treatment].
Topics: Administration, Oral; Dihydroxyphenylalanine; Drug Synergism; Drug Therapy, Combination; Humans; Parkinson Disease; Trihexyphenidyl | 1973 |
7 trial(s) available for trihexyphenidyl and dihydroxyphenylalanine
Article | Year |
---|---|
3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.
Topics: Aged; Clinical Trials as Topic; Dihydroxyphenylalanine; Disability Evaluation; Drug Interactions; Female; Humans; Male; Methyldopa; Middle Aged; Parkinson Disease; Time Factors; Trihexyphenidyl | 1973 |
[Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes].
Topics: Amantadine; Antiparkinson Agents; Dihydroxyphenylalanine; Drug Combinations; Drug Synergism; Humans; Parkinson Disease; Placebos; Thiothixene; Trihexyphenidyl | 1972 |
Anticholinergic withdrawal and benzhexol treatment in Parkinson's disease.
Topics: Adult; Aged; Dihydroxyphenylalanine; Disability Evaluation; Drug Synergism; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Placebos; Trihexyphenidyl | 1973 |
Parkinson disease treated with a suspected dopamine receptor agonist.
Topics: Adult; Aged; Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benztropine; Dihydroxyphenylalanine; Dopamine; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Piperazines; Placebos; Probenecid; Pyrimidines; Receptors, Cholinergic; Tremor; Trihexyphenidyl | 1974 |
Psychiatric changes in patients treated with levodopa. I. The clinical experiment.
Topics: Activities of Daily Living; Adjustment Disorders; Aged; Amitriptyline; Clinical Trials as Topic; Diazepam; Dihydroxyphenylalanine; Humans; Male; Mental Disorders; Middle Aged; Neurologic Examination; Parkinson Disease; Phenobarbital; Psychological Tests; Psychoses, Substance-Induced; Trihexyphenidyl | 1970 |
[Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
Topics: Administration, Oral; Adolescent; Adult; Aged; Analysis of Variance; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parkinson Disease; Trihexyphenidyl | 1971 |
Levodopa in Parkinsonism: the effects of withdrawal of anticholinergic drugs.
Topics: Dihydroxyphenylalanine; Drug Synergism; Drug Tolerance; Female; Humans; Male; Methods; Neurologic Manifestations; Orphenadrine; Parasympatholytics; Parkinson Disease; Salivation; Substance Withdrawal Syndrome; Time Factors; Tremor; Trihexyphenidyl | 1971 |
26 other study(ies) available for trihexyphenidyl and dihydroxyphenylalanine
Article | Year |
---|---|
Dopa-responsive dystonia: long-term treatment response and prognosis.
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Depression; Dihydroxyphenylalanine; Disability Evaluation; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Dystonia; Female; Follow-Up Studies; Gait; Humans; Infant; Longitudinal Studies; Male; Menstruation; Pregnancy; Pregnancy Complications; Prognosis; Trihexyphenidyl | 1991 |
Parkinson's tremor, relief by an antiaminic drug (BC 105). Discussion on the biochemical pathogenesis of Parkinsonian tremor.
Topics: Adult; Aged; Benzocycloheptenes; Dihydroxyphenylalanine; Ergolines; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Parkinson Disease; Piperidines; Promethazine; Thiophenes; Tremor; Trihexyphenidyl | 1972 |
Central nervous system and autonomic nervous system effects of amantadine and of some standard anti-Parkinson drugs.
Topics: Amantadine; Animals; Antiparkinson Agents; Atropine; Autonomic Nervous System; Body Temperature; Carbachol; Central Nervous System; Dihydroxyphenylalanine; Drug Interactions; Gastrointestinal Motility; Male; Mecamylamine; Mice; Mydriatics; Nicotine; Oxotremorine; Phenothiazines; Pupil; Rats; Trihexyphenidyl | 1973 |
Effect of several dopaminergic drugs and trihexyphenidyl on cholinergic parameters in the rat striatum.
Topics: Acetylcholine; Amantadine; Animals; Apomorphine; Choline; Corpus Striatum; Desipramine; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Piperazines; Rats; Time Factors; Trihexyphenidyl | 1974 |
Comparative effects of apomorphine, piribedil and other neurotropic agents on central analgesic-induced catatonia in the rat.
Topics: Amantadine; Analgesics, Opioid; Animals; Antiparkinson Agents; Apomorphine; Atropine; Benserazide; Benzyl Compounds; Catatonia; Dextroamphetamine; Dextromoramide; Dihydroxyphenylalanine; Dioxoles; Dose-Response Relationship, Drug; Humans; Male; Morphine; Piperazines; Pyrimidines; Rats; Time Factors; Trihexyphenidyl | 1974 |
Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity.
Topics: 1-Propanol; Animals; Atropine; Biperiden; Cyclohexanes; Cyclopentanes; Depression, Chemical; Dihydroxyphenylalanine; Methamphetamine; Motor Activity; Motor Neurons; Movement Disorders; Parasympathomimetics; Phenytoin; Piperidines; Rats; Reserpine; Spinal Cord; Sympathomimetics; Trihexyphenidyl | 1969 |
The effect of physostigmine and tetrabenazine on spinal motor control and its inhibition by drugs which influence reserpine rigidity.
Topics: 1-Propanol; Animals; Atropine; Biperiden; Dihydroxyphenylalanine; Electric Stimulation; Electromyography; Methamphetamine; Motor Neurons; Movement Disorders; Parasympatholytics; Phenytoin; Physostigmine; Piperidines; Rats; Reserpine; Spinal Cord; Spinal Nerves; Tetrabenazine; Trihexyphenidyl | 1969 |
Parkinsonism and hyperthyroidism.
Topics: Diazepam; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Hyperthyroidism; Male; Methimazole; Middle Aged; Parkinson Disease; Propranolol; Thyroidectomy; Trihexyphenidyl | 1974 |
Antagonism of tremorine-induced tremor by serotoninergic agents in mice. Interactions with levodopa.
Topics: 5-Hydroxytryptophan; Animals; Atropine; Benztropine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Male; Mice; Mice, Inbred Strains; Oxotremorine; Piperazines; Quinolines; Serotonin; Tremor; Tremorine; Trihexyphenidyl | 1972 |
Permanent dementia in idiopathic Parkinsonism treated with levodopa.
Topics: Aged; Amantadine; Brain; Dihydroxyphenylalanine; Electroencephalography; Humans; Male; Parkinson Disease; Psychoses, Substance-Induced; Pyridoxine; Trihexyphenidyl | 1973 |
Unilateral Parkinson's disease, clinical and neuropathologic findings. A case report.
Topics: Autopsy; Brain; Cerebral Ventricles; Dihydroxyphenylalanine; Humans; Male; Middle Aged; Neurons; Parkinson Disease; Substantia Nigra; Trihexyphenidyl | 1973 |
Levodopa and dopamine in cerebrospinal fluid.
Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benztropine; Carbidopa; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Parkinson Disease; Pyridoxine; Spinal Puncture; Trihexyphenidyl | 1973 |
Sporadic and familial parkinsonism and motor neuron disease.
Topics: Aged; Amantadine; Amyotrophic Lateral Sclerosis; Cerebellar Diseases; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Encephalitis; Female; Humans; Male; Middle Aged; Muscles; Nerve Degeneration; Norepinephrine; Parkinson Disease; Serotonin; Spinal Cord Diseases; Trihexyphenidyl | 1973 |
[Present-day treatment of parkinsonism in the aged].
Topics: Aged; Amantadine; Antiparkinson Agents; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Therapy, Combination; Humans; Middle Aged; Parkinson Disease; Trihexyphenidyl | 1973 |
Neurofibrillary tangles in progressive supranuclear palsy. Electron microscopic observations.
Topics: Aged; Amantadine; Brain; Brain Diseases; Bulbar Palsy, Progressive; Dementia; Dihydroxyphenylalanine; Female; Humans; Mesencephalon; Microtubules; Middle Aged; Nerve Degeneration; Neurofibrils; Olivary Nucleus; Ophthalmoplegia; Parkinson Disease, Postencephalitic; Pons; Spinal Cord; Substantia Nigra; Trihexyphenidyl | 1974 |
Oxotremorine antagonism by prolyl-leucyl-glycine-amide administered by different routes and with several anticholinergics.
Topics: Administration, Oral; Amides; Analysis of Variance; Animals; Behavior, Animal; Benztropine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Glycine; Injections, Intravenous; Injections, Subcutaneous; Leucine; Male; Mice; Mice, Inbred ICR; Oligopeptides; Oxotremorine; Parasympatholytics; Proline; Scopolamine; Time Factors; Trihexyphenidyl | 1974 |
Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
Topics: Aged; Amantadine; Cognition Disorders; Dihydroxyphenylalanine; Drug Therapy, Combination; Edema; Eye Movements; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Trihexyphenidyl; Xerostomia | 1974 |
[Attempt at treating parkinsonism with L-dopa and Artane].
Topics: Aged; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Humans; Male; Middle Aged; Parkinson Disease; Trihexyphenidyl | 1971 |
Effects of amantadine and of some synthetic antiparkinsonian drugs on the behavioral response to L-DOPA in mice.
Topics: Amantadine; Amitriptyline; Animals; Antiparkinson Agents; Atropine; Behavior, Animal; Dihydroxyphenylalanine; Diphenhydramine; Drug Synergism; Imipramine; Mice; Orphenadrine; Parasympatholytics; Pargyline; Trihexyphenidyl | 1971 |
Parkinsonism and dopa.
Topics: Dihydroxyphenylalanine; Humans; New Zealand; Orphenadrine; Parkinson Disease; Parkinson Disease, Postencephalitic; Trihexyphenidyl | 1969 |
Studies on the central effects of bulbocapnine.
Topics: 5-Hydroxytryptophan; Animals; Aporphines; Catalepsy; Cats; Cerebral Cortex; Dihydroxyphenylalanine; Diphenhydramine; Drug Antagonism; Drug Synergism; Electrodes, Implanted; Electroencephalography; Humans; Imipramine; Mice; Promethazine; Rabbits; Rats; Species Specificity; Time Factors; Trihexyphenidyl | 1971 |
[Effect of a combined L-Dopa and decarboxylase inhibitor (Ro 4-4602) therapy in parkinsonism patients. Quantitative analysis of bradykinesia using reaction times].
Topics: Aged; Carboxy-Lyases; Desipramine; Dihydroxyphenylalanine; Discrimination, Psychological; Drug Synergism; Electromyography; Humans; Infusions, Parenteral; Middle Aged; Movement Disorders; Parasympatholytics; Parkinson Disease; Reaction Time; Thalamus; Trihexyphenidyl | 1969 |
Action of L-Dopa in drug induced extrapyramidalism.
Topics: Adult; Chlorpromazine; Chronic Disease; Dihydroxyphenylalanine; Extrapyramidal Tracts; Female; Humans; Male; Middle Aged; Movement Disorders; Perphenazine; Schizophrenia; Smoking; Trifluoperazine; Trihexyphenidyl | 1970 |
Unusual arm movements with onset in childhood--a nosologic entity?
Topics: Child; Diagnosis, Differential; Diazepam; Dihydroxyphenylalanine; Diphenhydramine; Dystonia Musculorum Deformans; Humans; Male; Movement Disorders; Trihexyphenidyl | 1970 |
Reversal by levodopa of cholinergic hypersensitivity in Parkinson's disease.
Topics: Brain; Dihydroxyphenylalanine; Dopamine; Drug Hypersensitivity; Female; Handwriting; Humans; Injections, Intravenous; Male; Middle Aged; Movement Disorders; Neurologic Manifestations; Neurons; Parasympatholytics; Parasympathomimetics; Parkinson Disease; Physostigmine; Stimulation, Chemical; Trihexyphenidyl; Tropanes | 1971 |
Transitory procaine-induced Parkinsonism.
Topics: Chronic Disease; Dihydroxyphenylalanine; Female; Humans; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Procaine; Trihexyphenidyl | 1971 |